Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Product Specifications
CAS Number
2101829-58-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
130352-ML550 100 µL
NGFR (Tumor Necrosis Factor Receptor Superfamily Member 16, Gp80-LNGFR, Low Affinity Neurotrophin Receptor p75NTR, Low-affinity Nerve Growth Factor Receptor, NGF Receptor, p75 ICD, CD271, TNFRSF16) (MaxLight 550)
Ask
View Details 
MBS8104439-01 0.1 mg
Recombinant Anti-Von Willebrand Factor/vWF Antibody (HRP), Rabbit Monoclonal
Ask
View Details MBS8104439-02 5x 0.1 mg
Recombinant Anti-Von Willebrand Factor/vWF Antibody (HRP), Rabbit Monoclonal
Ask
View Details